|
|
Other links at Articles > Neurology and Neurosurgery |
| 1. |
New and Emerging Therapies for Multiple Sclerosis
|
|
|
Dr Mark Tullman discusses data on emerging therapies for MS presented at the 60th Annual AAN Meeting and how these therapies may fill currently unmet needs in the pharmacologic management of MS.
Medscape Neurology & Neurosurgery
|
| 2. |
DIAS-2 Revisited: Development of Desmoteplase for Stroke to Continue
|
|
|
After startling results of the DIAS-2 trial showed no benefit of the novel thrombolytic desmoteplase over placebo for ischemic stroke, the researchers and the company have had a good look at the data and conclude further study of the drug is probably warranted. Medscape Medical News
|
| 3. |
FTY720 (Fingolimod) for Relapsing Multiple Sclerosis
|
|
|
A recent Phase II study has demonstrated that oral FTY720 is effective in reducing disease activity in relapsing multiple sclerosis with a favorable adverse-effect profile. These results are awaiting confirmation in the three ongoing Phase III clinical trials
Expert Review of Neurotherapeutics
|
|
|
